clinical trial · NCT06403501
Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.·phase3·recruiting·n = 692
Acne VulgarisClascoteroneVehicle cream
brief summary
The primary objective of this study is to determine the safety and efficacy of clascoterone cream, 1%, versus the vehicle cream applied twice daily for 12 weeks in subjects with facial acne vulgaris.
started
May 20, 2024
primary completion
Oct 1, 2026
completion
Oct 1, 2026
last updated
Jul 9, 2025
official title
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Clinical Study to Evaluate the Efficacy and Safety of Clascoterone Cream 1% in Treatment of Subjects With Facial Acne Vulgaris
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol